S
Description
SCI Pharmtech, founded in 1987 by Siegfried Ltd. (Switzerland) and now listed on the Taiwan Stock Exchange, manufactures active pharmaceutical ingredients (APIs), advanced intermediates, and precision chemicals. Facilities in Taoyuan are FDA, EDQM, PMDA, and TFDA inspected with ISO 9001, ISO 14001, and OHSAS 18001 certifications, supplying quality-efficient APIs worldwide since 1989.